The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic implication of body composition changes in patients with borderline resectable/locally advanced pancreatic adenocarcinoma (PDAC) treated with mFOLFIRINOX.
 
Jong Hyuk Lee
No Relationships to Disclose
 
Hyehyun Jeong
No Relationships to Disclose
 
Yousun Ko
No Relationships to Disclose
 
Hyunseok Yoon
No Relationships to Disclose
 
Kyu-Pyo Kim
No Relationships to Disclose
 
Changhoon Yoo
Honoraria - AstraZeneca; Bayer; Boryung Pharmaceuticals; Bristol-Myers Squibb; Celgene; Eisai; Ipsen; MSD Oncology; Novartis; Roche/Genentech; SERVIER
Research Funding - AstraZeneca; Bayer; Boryung Pharmaceuticals; CKD pharm; Eisai; Lunit; SERVIER
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - Genome Insight (Inst); Roche/Genentech (Inst)
 
Sun Young Kim
Honoraria - Boryung; LG Chem; Merck
Consulting or Advisory Role - Guardant Health; Ono Pharmaceutical; Roche
Research Funding - Roche/Genentech (Inst)
Expert Testimony - Guardant Health